Form 4: Cunningham Patrick A. reports acquisition/exercise transactions in AVAH

Q: How many Aveanna Healthcare (AVAH) shares did Patrick Cunningham earn from performance-based RSUs?

Patrick Cunningham earned 19,016 shares from 2022 performance-based restricted stock units and 58,594 shares from 2023 performance-based restricted stock units. Both awards vested on February 14, 2026 , increasing his directly owned Aveanna common stock without requiring cash payment.

Q: Were Patrick Cunningham’s Aveanna Healthcare (AVAH) Form 4 transactions open-market purchases?

No, the transactions were equity awards , not open-market purchases. The Form 4 shows shares acquired at a price of $0 per share through vested performance-based restricted stock units and a new stock-settled restricted stock unit grant, rather than cash purchases in the market.

Q: What is the significance of the ESPP shares noted in the Aveanna Healthcare (AVAH) Form 4?

The Form 4 notes that Cunningham’s total 386,915 shares include 1,764 shares acquired under Aveanna’s Employee Stock Purchase Plan in December 2025 . This clarifies that a portion of his holdings comes from employee share purchases, in addition to incentive-based stock awards.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Cunningham Patrick A. reported acquisition or exercise transactions in a Form 4 filing for AVAH. The filing lists transactions totaling 91,797 shares. Following the reported transactions, holdings were 386,915 shares.

Insider Trade Summary

Net Buyer: 91,797 shares

Net Buy 3 txns

Insider Cunningham Patrick A.

Role Chief Compliance Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, par value $0.01 per share	19,016	$0.00	$0.00
Grant/Award	Common Stock, par value $0.01 per share	58,594	$0.00	$0.00
Grant/Award	Common Stock, par value $0.01 per share	14,187	$0.00	$0.00

Holdings After Transaction: Common Stock, par value $0.01 per share — 386,915 shares (Direct)

Footnotes (4)

F1. Represents shares earned upon vesting of performance-based restricted stock units issued pursuant to the Company's 2022 long-term incentive awards.
F2. Represents shares earned upon vesting of performance-based restricted stock units issued pursuant to the Company's 2023 long-term incentive awards.
F3. Grant of stock-settled restricted stock unit, subject to three-year cliff vesting.
F4. Includes 1,764 shares acquired under the Registrant's Employee Stock Purchase Plan (the "ESPP") in December 2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 02/17/2026 - 05:30 PM

FAQ

What insider transaction did Aveanna Healthcare (AVAH) report for Patrick A. Cunningham?

Aveanna Healthcare reported that Chief Compliance Officer Patrick A. Cunningham acquired equity awards totaling 91,797 shares of common stock on February 14, 2026. These came from vested performance-based restricted stock units and a new stock-settled restricted stock unit grant, all awarded at $0 per share.

How many Aveanna Healthcare (AVAH) shares did Patrick Cunningham earn from performance-based RSUs?

Patrick Cunningham earned 19,016 shares from 2022 performance-based restricted stock units and 58,594 shares from 2023 performance-based restricted stock units. Both awards vested on February 14, 2026, increasing his directly owned Aveanna common stock without requiring cash payment.

What new restricted stock unit grant did Aveanna Healthcare (AVAH) give its CCO?

Aveanna granted Chief Compliance Officer Patrick Cunningham 14,187 stock-settled restricted stock units on February 14, 2026. This grant is subject to three-year cliff vesting, meaning the units vest in full after three years, potentially delivering additional Aveanna common shares at that time.

How many Aveanna Healthcare (AVAH) shares does Patrick Cunningham own after the Form 4 transactions?

After the reported equity awards, Patrick Cunningham directly beneficially owned 386,915 shares of Aveanna common stock. This total includes 1,764 shares previously acquired under the company’s Employee Stock Purchase Plan in December 2025, along with the newly vested and granted awards.

Were Patrick Cunningham’s Aveanna Healthcare (AVAH) Form 4 transactions open-market purchases?

No, the transactions were equity awards, not open-market purchases. The Form 4 shows shares acquired at a price of $0 per share through vested performance-based restricted stock units and a new stock-settled restricted stock unit grant, rather than cash purchases in the market.

What is the significance of the ESPP shares noted in the Aveanna Healthcare (AVAH) Form 4?

The Form 4 notes that Cunningham’s total 386,915 shares include 1,764 shares acquired under Aveanna’s Employee Stock Purchase Plan in December 2025. This clarifies that a portion of his holdings comes from employee share purchases, in addition to incentive-based stock awards.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cunningham Patrick A.

(Last)

(First)

(Middle)

C/O AVEANNA HEALTHCARE HOLDINGS INC.

400 INTERSTATE NORTH PARKWAY SE

(Street)

ATLANTA

30339

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Aveanna Healthcare Holdings, Inc. [ AVAH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Compliance Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/14/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock, par value $0.01 per share	02/14/2026		A		19,016⁽¹⁾	A	$0	314,134⁽⁴⁾	D
Common Stock, par value $0.01 per share	02/14/2026		A		58,594⁽²⁾	A	$0	372,728	D
Common Stock, par value $0.01 per share	02/14/2026		A		14,187⁽³⁾	A	$0	386,915	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents shares earned upon vesting of performance-based restricted stock units issued pursuant to the Company's 2022 long-term incentive awards.

2. Represents shares earned upon vesting of performance-based restricted stock units issued pursuant to the Company's 2023 long-term incentive awards.

3. Grant of stock-settled restricted stock unit, subject to three-year cliff vesting.

4. Includes 1,764 shares acquired under the Registrant's Employee Stock Purchase Plan (the "ESPP") in December 2025.

	/s/ Jonathan Beckler, Attorney-in-Fact	02/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR